CN117042631A - 含有l-麦角硫因的组合物 - Google Patents

含有l-麦角硫因的组合物 Download PDF

Info

Publication number
CN117042631A
CN117042631A CN202280022582.6A CN202280022582A CN117042631A CN 117042631 A CN117042631 A CN 117042631A CN 202280022582 A CN202280022582 A CN 202280022582A CN 117042631 A CN117042631 A CN 117042631A
Authority
CN
China
Prior art keywords
mass
parts
srh
composition
egt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280022582.6A
Other languages
English (en)
Chinese (zh)
Inventor
松本淳
仲谷豪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nagase and Co Ltd
Original Assignee
Nagase and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nagase and Co Ltd filed Critical Nagase and Co Ltd
Publication of CN117042631A publication Critical patent/CN117042631A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
CN202280022582.6A 2021-04-14 2022-03-30 含有l-麦角硫因的组合物 Pending CN117042631A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2021-068583 2021-04-14
JP2021068583 2021-04-14
PCT/JP2022/015935 WO2022220123A1 (ja) 2021-04-14 2022-03-30 Ｌ－エルゴチオネイン含有組成物

Publications (1)

Publication Number Publication Date
CN117042631A true CN117042631A (zh) 2023-11-10

Family

ID=83639633

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280022582.6A Pending CN117042631A (zh) 2021-04-14 2022-03-30 含有l-麦角硫因的组合物

Country Status (5)

Country Link
US (1) US20240189283A1 (https=)
EP (1) EP4324336B1 (https=)
JP (1) JP7240565B2 (https=)
CN (1) CN117042631A (https=)
WO (1) WO2022220123A1 (https=)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5438151A (en) * 1993-06-28 1995-08-01 Bioxytech Process for the preparation of ergothioneine
CN112004936A (zh) * 2018-02-23 2020-11-27 长濑产业株式会社 麦角硫因生产方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10167490B2 (en) * 2012-12-21 2019-01-01 Ergo Health Llc Ergothioneine production through metabolic engineering
WO2019089878A1 (en) 2017-11-02 2019-05-09 Colorado Seminary, Owner and Operator of University of Denver Methods of treating microbial infection and inflammation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5438151A (en) * 1993-06-28 1995-08-01 Bioxytech Process for the preparation of ergothioneine
CN112004936A (zh) * 2018-02-23 2020-11-27 长濑产业株式会社 麦角硫因生产方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
N.M.HALLIDAY等: "Quantitative liquid chromatography–tandem mass spectrometry profiling of activated methyl cycle metabolites involved in LuxS-dependent quorum sensingin Escherichia coli", ANALYTICAL BIOCHEMISTRY, vol. 403, 22 April 2010 (2010-04-22), pages 26 *

Also Published As

Publication number Publication date
EP4324336A4 (en) 2025-03-26
US20240189283A1 (en) 2024-06-13
JP7240565B2 (ja) 2023-03-15
WO2022220123A1 (ja) 2022-10-20
EP4324336B1 (en) 2026-04-01
JPWO2022220123A1 (https=) 2022-10-20
EP4324336A1 (en) 2024-02-21

Similar Documents

Publication Publication Date Title
KR101277180B1 (ko) 콜라겐 산생 증강제와 그 제조 방법 및 용도
US12357614B2 (en) L-ergothioneine-containing composition
WO2005072684A1 (ja) マカ抽出物の製造方法
JPWO2015083554A1 (ja) ４Ｇ−Ｏ−α−Ｄ−グルコピラノシルルチンの結晶とその用途
TWI308152B (https=)
CN117042631A (zh) 含有l-麦角硫因的组合物
JP4822718B2 (ja) 新規ｃ−グリコシド化合物、コラーゲン産生促進剤、皮膚化粧料及び美容用飲食品
JP2013075831A (ja) 新規ヒドロキシスチルベン誘導体
JP7727671B2 (ja) ホモシステイン誘導体及びその製造方法、組成物、並びに、炎症抑制剤
HK40075066A (en) L-ergothioneine-containing composition
TWI918846B (zh) 升半胱胺酸衍生物及其製造方法、組成物、以及發炎抑制劑
BR112022017415B1 (pt) Composição contendo l-ergotioneína
BR122023019667B1 (pt) Método de produção de uma composição contendo l-ergotioneína e n, n-dimetil-l-2-tiohistidina e método de supressão de coloração da composição
JP5673091B2 (ja) 新規レスベラトロール誘導体
JP2014005246A (ja) 新規ケルセチン誘導体
JP2014028772A (ja) 新規レスベラトロール誘導体
JPH05213730A (ja) チロシナーゼ活性抑制剤
JP2024160657A (ja) 健康寿命増長促進剤、及び健康寿命増長促進剤の製造方法
US20200023017A1 (en) Genome stability enhancer
CN112912057A (zh) 含有聚酯型儿茶素a的化妆料组合物
HK1079209A (en) Anti-obesity agent
HK1196096A1 (en) Skin lightening agent and melanin production inhibitor

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination